Yakovlev A A, Lyzhin A A, Khaspekov L G, Guekht A B, Gulyaeva N V
Institute of Higher Nervous Activity and Neurophysiology, Moscow, Russia; Moscow Research and Clinical Center for Neuropsychiatry, Moscow, Russia.
Research Center of Neurology, Moscow, Russia.
Biomed Khim. 2017 Jan;63(1):27-31. doi: 10.18097/PBMC2017630127.
Cortexin, a drug containing hydrolyzed brain peptides, has long been used in clinics, but the mechanisms of its action remain obscure. We have hypothesized that cortexin-related neuroprotection is associated with the ability of the drug to inhibit brain proteases. Cortexin effectively inhibited brain caspase-8, while its effects on caspase-1, -3, -9, cathepsin B and calpain were much less pronounced or absent. In addition, we isolated a peptide fraction from cortexin holding all the inhibitory capacity of the original drug, but with a much more simple composition. Both cortexin and its fraction prevented neuronal damage in a culture model of glutamate-induced cell death. Neuroprotective effect of Cortexin may be mediated by inhibition of the initiator caspase-8 in the brain.
皮质素是一种含有水解脑肽的药物,长期以来一直在临床上使用,但其作用机制仍不清楚。我们推测,与皮质素相关的神经保护作用与该药物抑制脑蛋白酶的能力有关。皮质素能有效抑制脑半胱天冬酶-8,而其对半胱天冬酶-1、-3、-9、组织蛋白酶B和钙蛋白酶的作用则不那么明显或不存在。此外,我们从皮质素中分离出一种肽组分,它具有原始药物的所有抑制能力,但组成要简单得多。皮质素及其组分在谷氨酸诱导的细胞死亡培养模型中均能预防神经元损伤。皮质素的神经保护作用可能是通过抑制脑中起始半胱天冬酶-8来介导的。